Grantham, Mayo, Van Otterloo & Co (GMO)’s Erie Indemnity ERIE Stock Holding History
Bought
Maintained
Sold
Other funds holding ERIE
Grantham, Mayo, Van Otterloo & Co (GMO)'s ERIE Position: Q4 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Erie Indemnity (ERIE) in Q4 2022, closing a stake of 19,612 shares — an estimated $4.36M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ERIE in Q3 2022 and held it in 1 quarter. The position peaked at $4.36M in Q3 2022. 284 funds tracked by Wall St. Rank hold ERIE as of Q4 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Erie Indemnity position as of Q4 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 19,612 Erie Indemnity shares in Q4 2022, an estimated $4.36M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Erie Indemnity in Q3 2022 and held it in 1 quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Erie Indemnity position peaked at $4.36M in Q3 2022.
- 284 funds tracked by Wall St. Rank held Erie Indemnity as of Q4 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.